SN

Silvia Noiman

Seasoned Executive and Serial Entrepreneur

Israel

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Israel

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Bioinformatics
Biopharmaceuticals
Biotechnology
Business Strategy
Cell Biology
Clinical Development
Clinical Trials
Drug Development
Drug Discovery
Entrepreneurship
In Vitro
Life Sciences
Lifesciences
Molecular Biology
Oncology
Patents
Pharmaceutical Industry
Product Development
R
Small Molecules

Education

Lists including Silvia

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Vico Therapeutics

Series A

Total Funding: $120M

ABAC Therapeutics

Series A

Total Funding: $20M

Work Experience

TA
Tel Aviv University's Entrepreneurship Center

2019

  • Mentor

    2019

IB
Imel Biotherapeutics Inc

2019 - 2024

  • Founder, CEO & Board Member

    2019 - 2024

Sentaur Biosciences

2019 - 2024

  • Board Member

    2019 - 2024

KP
Kamari Pharma

2018 - 2023

  • Board Member

    2018 - 2023

PV
Pontifax Venture Capital

2010 - 2023

  • Venture partner, entrepreneur and executive

    2010 - 2023

VT
VICO Therapeutics B.V.

2019 - 2022

  • Board Member

    2019 - 2022

EP
Eloxx Pharmaceuticals

2013 - 2021

  • Founder, Board Member & CEO

    2013 - 2021

    http://www.eloxxpharma.com/

AT
ABAC Therapeutics

2018 - 2019

  • Board Member

    2018 - 2019

ProMining Therapeutics, LTD

2011 - 2015

  • Co-Founder & Executive Chairwoman

    2011 - 2015

Quiet Therapeutics

2010 - 2015

  • Co-Founder & Executive Chairwoman

    2010 - 2015